HomeCompareCITAY vs MRK

CITAY vs MRK: Dividend Comparison 2026

CITAY yields 3.59% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CITAY wins by $1020.22M in total portfolio value
10 years
CITAY
CITAY
● Live price
3.59%
Share price
$7.00
Annual div
$0.25
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1020.28M
Annual income
$968,411,466.34
Full CITAY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CITAY vs MRK

📍 CITAY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCITAYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CITAY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CITAY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CITAY
Annual income on $10K today (after 15% tax)
$304.87/yr
After 10yr DRIP, annual income (after tax)
$823,149,746.39/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CITAY beats the other by $823,141,417.98/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CITAY + MRK for your $10,000?

CITAY: 50%MRK: 50%
100% MRK50/50100% CITAY
Portfolio after 10yr
$510.17M
Annual income
$484,210,632.24/yr
Blended yield
94.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CITAY
No analyst data
Altman Z
0.3
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CITAY buys
0
MRK buys
0
No recent congressional trades found for CITAY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCITAYMRK
Forward yield3.59%2.76%
Annual dividend / share$0.25$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$1020.28M$56.8K
Annual income after 10y$968,411,466.34$9,798.13
Total dividends collected$1016.53M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CITAY vs MRK ($10,000, DRIP)

YearCITAY PortfolioCITAY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,417$717.34$11,206$366.19+$211.00CITAY
2$13,747$1,530.87$12,650$502.35+$1.1KCITAY
3$18,155$3,445.41$14,407$694.19+$3.7KCITAY
4$27,931$8,504.82$16,585$967.82+$11.3KCITAY
5$54,343$24,456.57$19,342$1,363.89+$35.0KCITAY
6$147,087$88,940.19$22,913$1,947.19+$124.2KCITAY
7$607,347$449,963.84$27,662$2,823.89+$579.7KCITAY
8$4,122,718$3,472,857.35$34,159$4,173.35+$4.09MCITAY
9$48,474,929$44,063,620.61$43,337$6,308.80+$48.43MCITAY
10$1,020,279,641$968,411,466.34$56,776$9,798.13+$1020.22MCITAY

CITAY vs MRK: Complete Analysis 2026

CITAYStock

COSCO SHIPPING Development Co., Ltd., together with its subsidiaries, provides vessel chartering and container leasing services. It operates through Shipping and Industry-Related Leasing, Container Manufacturing, and Investment and Financial Services segments. The company manufactures and sells containers; and offers operating leasing, equity or debt investment, and insurance brokerage, as well as financial leasing services in the areas of health care, education, energy, construction, and industrial communication. As of December 31, 2021, it had 74 container ships. The company was formerly known as China Shipping Container Lines Company Limited and changed its name to COSCO SHIPPING Development Co., Ltd. in December 2016. COSCO SHIPPING Development Co., Ltd. was founded in 1997 and is headquartered in Shanghai, the People's Republic of China.

Full CITAY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CITAY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CITAY vs SCHDCITAY vs JEPICITAY vs OCITAY vs KOCITAY vs MAINCITAY vs JNJCITAY vs ABBVCITAY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.